ENMC Encore Medical

AUSTIN, Texas, June 21 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) will present at the Jefferies Life Sciences Conference in New York at the Mandarin Oriental Hotel on Wednesday, June 28, 2006. Kenneth W. Davidson, Chairman and Chief Executive Officer and William W. Burke, Executive Vice President and Chief Financial Officer, will present at 8:00 a.m. Eastern time. The presentation will provide an overview of Encore's products, market opportunities and competitive position. A live audio webcast of the presentation will be accessible through Encore Medical Corporation's web site at http://www.encoremed.com/ . The webcast will be available for two weeks following the presentation. Encore Medical Corporation is a diversified orthopedic device company that develops, manufactures and distributes a comprehensive range of high quality orthopedic devices used by orthopedic surgeons, physicians, therapists, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries. Through its Orthopedic Rehabilitation Division, Encore is a leading distributor of electrical stimulation and other orthopedic products used for pain management, orthopedic rehabilitation, physical therapy, fitness and sport performance enhancement. Encore's Surgical Implant Division offers a comprehensive suite of reconstructive joint products and spinal implants. For more information, visit http://www.encoremed.com/ . Contact: William W. Burke, Executive Vice President - Chief Financial Officer (512) 832-9500 Media: Davis Henley, Vice President - Business Development (512) 832-9500 Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties, such as the completion of this transaction and the use of proceeds therefrom, the timely availability of new products, the impacts of competitive products and pricing, the ability to continue to obtain long-term financing, and other risks and uncertainties set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein. DATASOURCE: Encore Medical Corporation CONTACT: William W. Burke, Executive Vice President - Chief Financial Officer, +1-512-832-9500, or , or media, Davis Henley, Vice President - Business Development, +1-512-832-9500, or , both of Encore Medical Corporation Web site: http://www.encoremed.com/

Copyright